Home › Migraine › Michigan › Ann Arbor
Migraine clinical trials in Ann Arbor, MI
5 studies for Migraine are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of EVO756 in Adults With Migraine
RecruitingPhase 2
- Michigan Headache and Neurological Institute, Ann Arbor
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
RecruitingPhase 3
- Michigan Headache Pain & Neurological Institute, Ann Arbor
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- Michigan Head Pain and Neurological Institute, Ann Arbor
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- Michigan Head Pain & Neurological Institute, Ann Arbor
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
RecruitingPhase 3
- Michigan Headache & Neurological Institute /ID# 270942, Ann Arbor
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH12 studies
- Omaha, NE9 studies
- Austin, TX9 studies
- Aurora, CO8 studies
- Miami, FL8 studies
- Stamford, CT8 studies
- Atlanta, GA8 studies
- Washington, DC8 studies
- Phoenix, AZ7 studies
- Philadelphia, PA7 studies
- Tampa, FL7 studies
- San Diego, CA7 studies
Other studies in Ann Arbor
- Prostate Cancer26 studies
- Cancer (all types)25 studies
- Breast Cancer25 studies
- Lung Cancer23 studies
- Non-Small Cell Lung Cancer23 studies
- Colorectal Cancer22 studies
- Heart Failure21 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease15 studies
- Pancreatic Cancer14 studies
- Multiple Myeloma13 studies
- Atrial Fibrillation12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.